Killing of Skin-derived Tumor Cells by Mouse Dendritic Epidermal T-Cells

Cancer Research

Volumn 53, Issue 17, 1993, Pages 4014-4019

  Kaminski, Marek J ^a   Cruz, Ponciano D ^a   Bergstresser, Paul R ^a   Takashima, Akira ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CANCER CELL DESTRUCTION; CHROMIUM 51 RELEASE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE;

ANIMAL; CELL LINE, TRANSFORMED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; KERATINOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0027293952     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Scotto, J., Fears, T. R. and Fraumeni, J. F. Jr. Incidence of non-melanoma skin cancer in the United States. United States Department of Health and Human Service Publication, 83-2433: pp. 1-113. Washington, DC: United States Government Printing Office, 1983.
2. Hoover, R. and Fraumeni, J. F. Risk of cancer in renal-transplant recipients. Lancet, 2: 55, 1973.
3. Greene, M. H., Young, T. I. and Clark, W. H. Jr. Malignant melanoma in renal-transplant recipients. Lancet, 1: 1196, 1981.
4. Stingl, G. and Shevach, E. M. Langerhans cells as antigen-presenting cells. In: G. Schuler (ed.), Epidermal Langerhans Cells, pp. 159-190. Boca Raton, FL: CRC Press, Inc. 1991.
5. Granstein, R. D., Parrish, J. A., McAuliffe, D. J., Waltenbaugh, C. and Greene, M. I. Immunologic inhibition of ultraviolet radiation-induced tumor suppressor cell activity. Science (Washington DC), 224: 615-617, 1984.
6. Grabbe, S., Bruvers, S. Gallo, R. L., Knisely, T. L., Nazareno, R. and Granstein, R. D. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146: 3656-3661, 1991.
7. Tigelaar, R. E., Lewis, J. M. Nixon-Fulton, J. L. and Bergstresser, P. R. Thy-1 antigen-bearing dendritic epidermal cells in mice. In: E. A. Goldsmith (ed.), Biochemistry and Physiology of the Skin, pp. 1164-1187. New York: Oxford University Press, 1991.
8. Allison, J. P. and Havran, W. L. The immunobiology of T cells with invariant γδ antigen receptors. Annu. Rev. Immunol. 9: 679-705, 1991.
9. Nixon-Fulton, J. L., Hackett, J. Jr., Bergstresser, P. R., Kumar, V. and Tigelaar, R. E. Phenotypic heterogeneity and cytotoxic activity of Con A and IL-2-stimulated cultures of mouse Thy-1+ epidermal cells. J. Invest. Dermatol. 91: 62-68, 1988.
10. + dendritic epidermal cell lines. J. Leukocyte Biol. 43: 502-508, 1988.
11. + dendritic epidermal cells. Nature (Lond.), 328: 263-266, 1987.
12. + dendritic epidermal cells. Cell, 55: 837-847, 1988.
13. Janeway, C. A. Jr., Jones, B. and Hayday, A. Specificity and function of T cells bearing γδ receptors. Immunol. Today, 9: 73-76, 1988.
14. Havran, W. L., Chien, Y. H. and Allison, J. P. Recognition of self antigens by skin-derived T cells with invariant γδ antigen receptors. Science (Washington DC), 252: 1430-1432, 1991.
15. Bergstresser, P. R., Cruz, P. D. Jr. and Takashima, A. Dendritic epidermal T cells: lessons from mice for humans. J. Invest. Dermatol. 100: 80S-83S, 1993.
16. Havran, W. L., Poenie, M. Tigelaar, R. E., Tsien, R. Y. and Allison, J. P. Phenotypic and functional analysis of γδ T cell receptor-positive murine dendritic epidermal clones. J. Immunol. 142: 1422-1428, 1989.
17. + dendritic epidermal cells in mice: precursor frequency analysis and cloning of con-canavalin A-reactive cells. J. Invest. Dermatol. 90: 671-678, 1988.
18. + dendritic cells. J. Invest. Dermatol. 84: 491-495, 1985.
19. Takashima, A. and Grinnell, F. Human keratinocyte adhesion and phagocytosis promoted by fibronectic. J. Invest. Dermatol. 83: 352-358, 1984.
20. Matsue, H., Romberg, K. G., Takashima, A. Kamen, B. A., Anderson, R. G. and Lacey, S. W. Folate receptor allows cells to grow in low concentrations of 5-meth-yltetrahydrofolate. Proc. Natl. Acad. Sci. USA, 89: 6006-6009, 1992.
21. Matsue, H., Cruz, P. D. Jr., Bergstresser, P. R. and Takashima, A. Profiles of cytokine mRNA expressed by dendritic epidermal T cells in mice. J. Invest. Dermato. in press, 1993.
22. Perussia, B. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr. Opin. Immunol. 3: 49-55, 1991.
23. + intraepithelial lymphocytes. Science (Washington DC), 243: 1716-1718, 1989.
24. Mami-Chouaib, F., Miossec, C. Del Porto, P., Flament, C. Triebel, F. and Hercent, T. T cell target 1 (TCT.l): a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytes. J. Exp. Med. 172: 1071-1082, 1990.
25. + cytotoxic lymphocyte precursors activated by allogeneic or autologous stimulator cells. J. Immunol. 145: 2827-2832, 1990.
26. Dalloul, A., Laroche, L. Bagot, M., Mossalayi, M. D., Fourcade, C. Thacker, D. J., Hogge, D. E. Merle-Beral, H., Debre, P. and Schmitt, C. Interleukin-7 is a growth factor for Sézary lymphoma cells. J. Clin. Invest. 90: 1054-1060, 1992.
27. Lynch, D. H. and Miller, R. E. Induction of murine lymphokine-activated killer cells by recombinant IL-7. J. Immunol. 145: 1983-1990, 1990.
28. Alderson, M. R., Sassenfeld, H. M. and Widmer, M. B. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J. Exp. Med. 172: 577-587, 1990.
29. Bertagnolli, M. and Herrmann, S. IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. J. Immunol. 145: 1706-1712, 1990.
30. Stotter, H., Custer, M. C., Bolton, E. S., Guedez, L. and Lotze, M. T. IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. J. Immunol. 146: 150-155, 1991.
31. Jicha, D. L., Mule, J. J. and Rosenberg, S. A. Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J. Exp. Med. 174: 1511-1515, 1991.
32. + T cell-dependent tumor rejection. J. Exp. Med. 174: 1291-1298, 1991.
33. Rheins, L. A., Young, E. M., Nordlund, M. L., Berning, R. B. and Nordlund, J. J. Rapid induction of Thy-1 antigenic markers on keratinocytes and epidermal immune cells in the skin of mice following topical treatment with common preservatives used in topical medications and in foods. J. Invest. Dermatol. 89: 489-494, 1987.
34. + epidermal cell numbers. J. Exp. Med. 171: 1027-1041, 1990.
35. Edelbaum, D., Cruz, P. D. Jr., Bergstresser, P. R. and Takashima, A. Dendritic epidermal T cells (DETC) display selective binding to keratinocytes (KC) in vitro. Clin. Res. 40: 498A, 1992.
36. Russell, J. H., Musil, L. and McCulley, D. E. Loss of adhesion. A novel and distinct effect of the cytotoxic T lymphocyte-target interaction. J. Immunol. 140: 427-432, 1988.
37. + dendritic epidermal cells contain a killer protein perforin. Int. Immunol. 2: 1113-1116, 1990.
38. Baxter, C. S., Andringa, A. Chalfin, K. and Miller, M. L. Comparative histomor-phometric changes in SENCAR mouse epidermis in response to multiple treatments with complete and stage-specific tumor promoting agents. Carcinogenesis (Lond.), 10: 1855-1861, 1989.
39. + dendritic cells following topical application of phorbol diesters and mezerein. Carcinogenesis (Lond.), 9: 1563-1568, 1988.
40. Alcalay, J. and Kripke, M. L. Antigen-presenting activity of draining lymph node cells from mice painted with a contact allergen during ultraviolet carcinogenesis. J. Immunol. 146: 1717-1721, 1991.
41. Aberer, W., Romani, N. Elbe, A. and Stingl, G. Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells. J. Immunol. 136: 1210-1216, 1986.
42. Bachelez, H., Flageul, B. Degos, L., Boumsell, L. and Bensussan, A. TCR γδ bearing T lymphocytes infiltrating human primary cutaneous melanomas. J. Invest. Dermatol. 98: 369-374, 1992.
43. Yuspa, S. H. Hawley-Nelson, P., Koehler, B. and Stanley, J. R. A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res. 40: 4694-4703, 1980.
44. Stackpole, C. W. Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma. Nature (Lond.), 289: 798-800, 1981.
45. Niederkorn, J., Sanborn, G. E. and Scarbrough, E. E. Mouse model of brachytherapy in consort with enucleation for treatment of malignant intraocular melanoma. Arch. Ophthalmol. 108: 865-868, 1990.
46. Yasmura, Y., Tashijan, A. H. Jr. and Sato, G. H. Establishment of four functional, clonal strains of animal cells in culture. Science (Washington DC), 154: 1186-1189, 1966.
47. Patek, P. Q., Collins, J. L. and Conn, M. Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis. Nature (Lond.), 276: 510-511, 1978.
48. O'Connel, K. A. and Edidin, M. A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells. J Immunol. 144: 521-525, 1990.
49. Kiessling, R., Klein, E. and Wigzell, H. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Mohoney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5: 112-117, 1975.